Prognosis
U.S. Cases Rise 0.7%; Pfizer Trial Shows Progress: Virus Update
This article is for subscribers only.
Researchers monitoring Pfizer Inc.’s vaccine trial have reported no safety problems even after more than 12,000 people received their second of two doses. JPMorgan Chase & Co. sent some of its Manhattan workers home after an employee in equities trading tested positive.
Joe Biden’s advisers are developing plans to distribute a coronavirus vaccine if he were to be elected president as his campaign monitors the Trump administration’s effort to deliver a drug for signs of political interference.